Covid-19: Chinese researchers say virus evolved in 2 types

The coronavirus has evolved into two major types, with differing transmission rates and geographical distribution, according to a study published in the National Science Review yesterday. A group of Chinese scientists analysed 103 coronavirus genomes and identified mutations in 149 sites across the strains. They found that one type, which they called the L type, was more

Read More


In the last 24 hours there were almost 9 times more cases reported outside China than inside China. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 2 March 2020

The number of cases in China continues to decline. Yesterday, China reported 206 cases of COVID-19 to WHO, the lowest since the 22nd of January. Only 8 cases were reported outside Hubei province yesterday. Outside China, a total of 8739 cases of COVID-19 have been reported to WHO from 61 countries, with 127 deaths. In the

Read More


Canada is investing $6.9 million in stem cell research

The Canadian government is investing almost $7 million in stem cell research and regenerative medicine. William Amos, Parliamentary Secretary to the Minister of innovation, Science and Industry, was at Maisonneuve-Rosemont Hospital Monday to announce that $6.9 million would go to the Stem Cell Network’s competitive research funding program. “Stem cell and regenerative medicine are a

Read More


In Situ Printing of Adhesive Hydrogel Scaffolds for the Treatment of Skeletal Muscle Injuries

Biomedical engineers at the UConn School of Dental Medicine recently developed a handheld 3D bioprinter that could revolutionize the way musculoskeletal surgical procedures are performed. The bioprinter, developed by Dr. Ali Tamayol, associate professor in the School of Dental Medicine biomedical engineering department, enables surgeons to deposit scaffolds–or materials to help support cellular and tissue

Read More


COVID-19 a Reminder of the Challenge of Emerging Infectious Diseases. A new paper of NIH scientists published on NEJM

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Read More